From: A gene expression profile indicative of early stage HER2 targeted therapy response
Cell line name | IC50± SD (μM) lapatinib | IC50± SD (μM) neratinib | IC50± SD (μM) afatinib | |
---|---|---|---|---|
Lapatinib Sensitive Cell Lines | BT474 | 0.036 ± 0.015 | 0.0019 ± 0.00046 | 0.00323 ± 0.00075 |
SKBR3 | 0.080 ± 0.017 | 0.00226 ± 0.00008 | 0.0075 ± 0.005 | |
Lapatinib Insensitive Cell Line | MDAMB453 | 6.08 ± 0.825 | 0.820 ± 0.140 | 1.59 ± 0.179 |